Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Imaging Study to Investigate Safety and Diagnostic Performance of 18F rhPSMA 7.3 PET Ligand in Suspected Prostate Cancer Recurrence

ClinicalTrials.gov ID: NCT04186845

Public ClinicalTrials.gov record NCT04186845. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 2:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Phase 3, Multi Center, Single-arm, Imaging Study Investigating the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) PET Ligand in Men With Suspected Prostate Cancer Recurrence Based on Elevated PSA Following Prior Therapy (SPOTLIGHT)

Study identification

NCT ID
NCT04186845
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Blue Earth Diagnostics
Industry
Enrollment
391 participants

Conditions and interventions

Interventions

  • Positron emission tomography scan Diagnostic Test
  • rhPSMA-7.3 (18F) Injection Drug

Diagnostic Test · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 3, 2020
Primary completion
Apr 27, 2021
Completion
Apr 27, 2021
Last update posted
Sep 21, 2025

2020 – 2021

United States locations

U.S. sites
25
U.S. states
13
U.S. cities
24
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35233
Tower Urology Los Angeles California 90048
University of California Irvine Medical Center (UCIMC) Orange California 92868
John Wayne Cancer Institute Santa Monica California 90403
Emory University Hospital Atlanta Georgia 30322
Northside Hospital Austell Georgia 30342
Northshore University HealthSystem Evanston Illinois 60201
Loyola University Medical Center Maywood Illinois 60153
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University Baltimore Maryland 21287
Chesapeake Urology Research Associates Towson Maryland 21204
University of Michigan Ann Arbor Ann Arbor Michigan 48109
Karmanos Cancer Institute Detroit Michigan 48201
Washington University School of Medicine St Louis Missouri 63110
Queens Hospital Center (QHC - Queens Cancer Center Jamaica New York 11432
Mount Sinai Faculty Practice Associates New York New York 10029
Stony Brook University Stony Brook New York 11794
Montefiore Hospital The Bronx New York 10461
Duke University Medical Center Durham North Carolina 27701
University Hospitals Cleveland Medical Center Cleveland Ohio 44106
Cleveland Clinic Cleveland Ohio 44195
MidLantic Urology Philadelphia Pennsylvania 19004
MD Anderson Hospital Houston Texas 77054
Urology San Antonio San Antonio Texas 78229
University of Virginia - Health Science Center Charlottesville Virginia 22908
Virginia Oncology Associates Norfolk Virginia 23502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04186845, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 21, 2025 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04186845 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →